1. Pashos LC., Botteman MF., Laskin LB. et al. Bladder cancer: epidemiology, diagnosis and management. Cancer Pract. 2002; 10: 311
2. 20. González J. Guías de diagnóstico y tratamiento en cáncer de vejiga.2008.
3. Mendelsohn J., Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J. Clin. Oncol. 2003; 89: 344–349.
4. Neal DE., Marsh C., Bennett MK., Abel PD., Hall RR., Sainsbury JR., Harris AL.. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet.1985; 1: 366–368.
5. Kristensen JK.., Lose G., Lund F., Nexo E. Epidermal growth factor in urine from patients with urinary bladder tumors. Eur. Urol. 1988 14: 313–314.
6. Gonzalez G, Crombet T, Catala M, Mirabal V, Hernandez JC, Gonzalez Y, et al. A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial. Ann Oncol 1998; 9(4):431–5.
7. Gonzalez, G., Crombet, T., Neninger, E., Viada, C., and Lage, A. Therapeutic vaccination with epidermal growth factor (EGF) in advanced lung cancer: analysis of pooled data from three clinical trials. Hum Vaccin. 2007, 3: 8-13.
8. Crombet T., Neninger E., Catalá M., García B., Leonard I., Martínez L., González G., Pérez R., Lage A. Treatment of NSCLC Patients with an EGF-Based Cancer Vaccine. Cancer Biology & Therapy 2006, 5:2, 145-149.
9. Neninger E., de la Torre A., Osorio M. Catalá M., Bravo I., Mendoza M., Abreu A., Acosta S., Rives R., del Castillo C., González M., Viada C., GarcÍa B., Crombet T., González G., Lage A. Phase II Randomized Controlled Trial of an Epidermal Growth Factor Vaccine in Advanced NSCLC. JCO 2008 26(9) 1462-68.
10. García B., Neninger E., de la Torre A., Leonard I., Martínez R., Viada C., González G., Mazorra Z., Lage A., Crombet T. Effective Inhibition of the Epidermal Growth Factor/Epidermal Growth Factor Receptor Binding by Anti-Epidermal Growth Factor Antibodies Is Related to Better Survival in Advanced Non Small-Cell Lung Cancer PatientsTreated with the Epidermal Growth Factor Cancer Vaccine. Clin Cancer Res 2008; 14(3) February